Annual total expenses:
$494.23M+$21.38M(+4.52%)Summary
- As of today (June 2, 2025), FOLD annual total expenses is $494.23 million, with the most recent change of +$21.38 million (+4.52%) on December 31, 2024.
- During the last 3 years, FOLD annual total expenses has fallen by -$11.20 million (-2.22%).
- FOLD annual total expenses is now -7.39% below its all-time high of $533.66 million, reached on December 31, 2022.
Performance
FOLD Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$133.20M-$534.00K(-0.40%)Summary
- As of today (June 2, 2025), FOLD quarterly total expenses is $133.20 million, with the most recent change of -$534.00 thousand (-0.40%) on March 31, 2025.
- Over the past year, FOLD quarterly total expenses has increased by +$1.12 million (+0.85%).
- FOLD quarterly total expenses is now -24.09% below its all-time high of $175.48 million, reached on September 30, 2018.
Performance
FOLD Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
FOLD Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.5% | +0.8% |
| 3 y3 years | -2.2% | -10.4% |
| 5 y5 years | +2.3% | -3.2% |
FOLD Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -7.4% | +4.5% | -10.4% | +19.3% |
| 5 y | 5-year | -7.4% | +4.5% | -12.7% | +19.3% |
| alltime | all time | -7.4% | +7388.4% | -24.1% | +1201.8% |
FOLD Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $133.20M(-0.4%) |
| Dec 2024 | $494.23M(+4.5%) | $133.74M(+14.6%) |
| Sep 2024 | - | $116.72M(+4.5%) |
| Jun 2024 | - | $111.70M(-15.4%) |
| Mar 2024 | - | $132.08M(+11.2%) |
| Dec 2023 | $472.85M(-11.4%) | $118.77M(+0.2%) |
| Sep 2023 | - | $118.53M(+5.9%) |
| Jun 2023 | - | $111.89M(-9.5%) |
| Mar 2023 | - | $123.66M(-4.0%) |
| Dec 2022 | $533.66M(+5.6%) | $128.84M(+12.1%) |
| Sep 2022 | - | $114.96M(-18.6%) |
| Jun 2022 | - | $141.23M(-5.0%) |
| Mar 2022 | - | $148.63M(-2.6%) |
| Dec 2021 | $505.43M(+0.1%) | $152.57M(+28.6%) |
| Sep 2021 | - | $118.66M(+3.0%) |
| Jun 2021 | - | $115.23M(-3.2%) |
| Mar 2021 | - | $118.99M(-11.8%) |
| Dec 2020 | $504.74M(+4.5%) | $134.94M(+13.2%) |
| Sep 2020 | - | $119.16M(+5.5%) |
| Jun 2020 | - | $112.98M(-17.9%) |
| Mar 2020 | - | $137.65M(-4.2%) |
| Dec 2019 | $482.98M(+15.9%) | $143.67M(+36.5%) |
| Sep 2019 | - | $105.28M(-12.3%) |
| Jun 2019 | - | $120.08M(+5.4%) |
| Mar 2019 | - | $113.94M(+12.2%) |
| Dec 2018 | $416.72M(+68.2%) | $101.53M(-42.1%) |
| Sep 2018 | - | $175.48M(+158.3%) |
| Jun 2018 | - | $67.94M(-5.3%) |
| Mar 2018 | - | $71.78M(-8.1%) |
| Dec 2017 | $247.81M(+37.7%) | $78.11M(+20.3%) |
| Sep 2017 | - | $64.93M(+22.1%) |
| Jun 2017 | - | $53.17M(+3.0%) |
| Mar 2017 | - | $51.61M(+1.8%) |
| Dec 2016 | $180.02M(+42.8%) | $50.71M(-0.9%) |
| Sep 2016 | - | $51.17M(+33.4%) |
| Jun 2016 | - | $38.35M(-3.6%) |
| Mar 2016 | - | $39.80M(-1.5%) |
| Dec 2015 | $126.05M | $40.39M(+10.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $36.74M(+42.0%) |
| Jun 2015 | - | $25.86M(+12.2%) |
| Mar 2015 | - | $23.05M(+7.3%) |
| Dec 2014 | $69.89M(+11.7%) | $21.49M(+21.4%) |
| Sep 2014 | - | $17.69M(+17.0%) |
| Jun 2014 | - | $15.13M(-2.9%) |
| Mar 2014 | - | $15.58M(+10.3%) |
| Dec 2013 | $62.56M(-12.3%) | $14.13M(-6.9%) |
| Sep 2013 | - | $15.17M(-5.2%) |
| Jun 2013 | - | $16.00M(-7.2%) |
| Mar 2013 | - | $17.25M(+8.3%) |
| Dec 2012 | $71.34M(-1.4%) | $15.92M(-5.9%) |
| Sep 2012 | - | $16.92M(-15.4%) |
| Jun 2012 | - | $19.98M(+7.9%) |
| Mar 2012 | - | $18.52M(-0.8%) |
| Dec 2011 | $72.32M(+27.4%) | $18.66M(-1.4%) |
| Sep 2011 | - | $18.93M(+0.9%) |
| Jun 2011 | - | $18.76M(+17.5%) |
| Mar 2011 | - | $15.96M(-8.6%) |
| Dec 2010 | $56.76M(-19.1%) | $17.46M(+31.6%) |
| Sep 2010 | - | $13.27M(+4.6%) |
| Jun 2010 | - | $12.69M(-5.0%) |
| Mar 2010 | - | $13.35M(-11.1%) |
| Dec 2009 | $70.19M(+19.1%) | $15.01M(-18.4%) |
| Sep 2009 | - | $18.39M(-4.3%) |
| Jun 2009 | - | $19.21M(+9.3%) |
| Mar 2009 | - | $17.57M(-8.6%) |
| Dec 2008 | $58.92M(+23.8%) | $19.22M(+48.4%) |
| Sep 2008 | - | $12.95M(-9.4%) |
| Jun 2008 | - | $14.30M(+14.9%) |
| Mar 2008 | - | $12.45M(-18.5%) |
| Dec 2007 | $47.59M(+1.6%) | $15.27M(+29.3%) |
| Sep 2007 | - | $11.81M(+14.8%) |
| Jun 2007 | - | $10.28M(+0.5%) |
| Mar 2007 | - | $10.23M |
| Dec 2006 | $46.86M(+124.9%) | - |
| Dec 2005 | $20.83M(+215.6%) | - |
| Dec 2003 | $6.60M | - |
FAQ
- What is Amicus Therapeutics annual total expenses?
- What is the all time high annual total expenses for Amicus Therapeutics?
- What is Amicus Therapeutics annual total expenses year-on-year change?
- What is Amicus Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Amicus Therapeutics?
- What is Amicus Therapeutics quarterly total expenses year-on-year change?
What is Amicus Therapeutics annual total expenses?
The current annual total expenses of FOLD is $494.23M
What is the all time high annual total expenses for Amicus Therapeutics?
Amicus Therapeutics all-time high annual total expenses is $533.66M
What is Amicus Therapeutics annual total expenses year-on-year change?
Over the past year, FOLD annual total expenses has changed by +$21.38M (+4.52%)
What is Amicus Therapeutics quarterly total expenses?
The current quarterly total expenses of FOLD is $133.20M
What is the all time high quarterly total expenses for Amicus Therapeutics?
Amicus Therapeutics all-time high quarterly total expenses is $175.48M
What is Amicus Therapeutics quarterly total expenses year-on-year change?
Over the past year, FOLD quarterly total expenses has changed by +$1.12M (+0.85%)